Aytu BioPharma, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • June 7th, 2021 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 7th, 2021 Company Industry JurisdictionAytu BioPharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: